| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.08 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.08 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.08 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.073 | 0.08 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |